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Abstract
Background: Toxoplasma gondii is a worldwide protozoan parasite of felids which can infect almost all warm-
blooded animals, including humans. Free-roaming chickens are good indicators of environmental contamination
with T. gondii oocysts because they feed from the ground. Previous research has demonstrated a high
seroprevalence of T. gondii in domestic animals on St. Kitts but little is known about the genotypes circulating in
the environment.
Methods: Hearts and brains from 81 free-roaming chickens in St. Kitts were digested and inoculated into 243 Swiss
Webster mice in a bioassay. DNA was extracted from digested chicken tissues and the brains of all mice, and
screened for T. gondii. Positive samples were genotyped using restriction fragment length polymorphism. Chicken
sera were also screened for T. gondii antibodies using a modified agglutination test (MAT).
Results: Overall, 41% (33 out of 81) of chickens were positive for T. gondii either by serology and/or by PCR.
Antibodies to T. gondii were detected by MAT in 32% (26 out of 81) of chickens, and T. gondii DNA was detected in
mouse brains representing 26% (21 out of 81) of chickens. Genotyping of 21 DNA isolates, using polymorphisms at
10 loci, including SAG1, SAG2 (5′-3′ SAG2 and alt.SAG2), SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico,
revealed that 7 were ToxoDB genotype #141, 6 were #1 (Type II), 3 were #13, 3 were #265, one was #264 and one
was #2 (Type III). Genotypes #13 and #141 appear to be more virulent.
Conclusions: The results of this study highlight the greater genetic diversity of T. gondii circulating in the
Caribbean region, with potentially different degrees of virulence to humans.
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Background
Toxoplasma gondii is a parasite of felids which can infect
almost all warm-blooded animals, including humans [1].
Worldwide seroprevalences vary but it has been
suggested that around one third of people have been
infected with this parasite [2]. Transmission routes in-
clude ingestion of tissue cysts in infected meat, ingestion
of sporulated oocysts (shed by felids) in contaminated
food, water, or directly from the environment, and via
vertical transmission, if a woman experiences a primary
infection during pregnancy. Symptoms of toxoplasmosis
are usually mild; however, immune-compromised people
and congenitally infected infants can suffer severe, and
even fatal, clinical signs [3].
Different factors may affect the severity of toxoplas-
mosis, including the infecting stage of the parasite, the
size of inoculating dose, and the virulence of the infect-
ing strain [4]. Historically, T. gondii was thought to have
a clonal population structure comprising three dominant
lineages (Types I, II and III) based on restriction frag-
ment length polymorphism [5, 6]. However, there are
indications of greater genetic variability with severe
cases of toxoplasmosis in patients from South America
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being linked to genetically distinct strains of T. gondii,
highlighting a greater genetic variability than previously
thought [7, 8].
In 2002, Dubey et al. [9] initiated a worldwide survey
of T. gondii in free-roaming chickens with the goal of
characterising the genetic diversity of T. gondii on a
global basis [10]. Free-roaming chickens are considered
one of the most important hosts for studying the
epidemiology of T. gondii because they feed from the
ground and are therefore good indicators of environ-
mental contamination with oocysts [10]. Also, the tissues
of infected chickens are a good source of infection for
cats, and potentially for humans if the meat is consumed
undercooked. Strains of T. gondii have been character-
ized from free-roaming chickens in South America [9],
Central America [11], the Caribbean [12], Asia [13],
Africa [14] and Europe [15], and it is becoming apparent
that isolates from South America, in particular Brazil,
are genetically distinct [16].
Previous research in St. Kitts has demonstrated a high
seroprevalence of T. gondii in domestic and feral cats
[17, 18], as well as African green monkeys [19], livestock
animals [20, 21] and dogs [22]. Genetic characterization
of T. gondii isolated from livestock heart samples at the
St. Kitts abattoir [21] and from feral cats [18] and dogs
[22] revealed that the Type III genotype was predomin-
ant which was similar to other findings from Caribbean
islands in this region [12], although atypical genotypes
have also been reported [18, 21, 22].
In order to investigate the diversity of T. gondii geno-
types circulating in the Caribbean, we isolated and
genetically characterised viable isolates from free-
roaming chickens in St. Kitts.
Methods
Animals
This study was carried out between September 2014
and December 2014, following ethical approval from
the Institutional Animal Care and Use Committee at
RUSVM (Project Submission 30/020). Free-roaming
chickens (n = 81) were collected, with permission from St.
Kitts and Nevis Department of Agriculture and Chief
Veterinary Officer, from 9 different locations (9 chickens
from each) around the island (Fig. 1). Chickens were
euthanized humanely by lethal injection and blood, heart
and brain were collected from each. Sera were isolated as
Fig. 1 Map of St. Kitts showing nine areas where chickens were collected and the genotypes identified in each area from this study and previous
studies (italicised bold) in St. Kitts [20, 24] (map adapted from mapsof.net)
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previously described [21] and stored at -20 °C until
required. Hearts and brains were transferred to re-sealable
bags prior to processing as described below.
Serological examination
Aliquots of chicken sera were tested at the Toxoplasma
Reference Laboratory (Reims, France) for reactive T.
gondii antibodies using a modified agglutination test
(MAT) [23]. Serum samples with an antibody titre of
greater than or equal to 1:6 were considered positive.
Bioassay of chicken tissues for T. gondii
Hearts and brains from all 81 chickens were digested in
acid-pepsin solution as previously described [21], with
the following modifications: the brain and heart from
each chicken were pooled, homogenised in 25 ml
(approximately five volumes (w/v)) 0.9% saline solu-
tion and then mixed with 25 ml (approximately five
volumes (w/v)) acid-pepsin solution (which had been
pre-warmed to 37 °C). After processing, the resulting
pellet was resuspended in 10 ml PBS prior to being
neutralized with 7.5 ml 1.2% sodium carbonate and centri-
fuged at 1200× g for 10 min. Two ml sterile saline solution
containing 400 IU/ml penicillin and 400 μg/ml strepto-
mycin were used to resuspend the final pellet.
Three Swiss CD-1® IGS mice (Charles River Labora-
tory, Boston, MA, USA) per chicken were each inocu-
lated with 400 μl of homogenate, and 400 μl was kept
for DNA extraction (see below). Mice were monitored
twice daily and euthanized either when they showed
clinical signs of T. gondii infection, or when they
reached the end of the experiment (day 28 post inocula-
tion). Immediately after euthanasia, mice were bled by
cardiac puncture, and sera were isolated following
centrifugation of clotted whole blood at 2000× g for
5 min and stored at -20 °C. Sera were tested for T.
gondii-specific antibodies using an indirect ELISA (ID
Screen® Toxoplasmosis Indirect Multi-species, IDvet,
Montpellier, France) according to manufacturer’s in-
structions. Brain and right lung from each mouse were
transferred to clean 2 ml tubes and stored at -80 °C for
DNA extraction and genotyping.
Detection of T. gondii DNA in digested chicken tissues
DNA was extracted from 400 μl of digested tissue hom-
ogenate per chicken using the Wizard® genomic DNA
purification protocol (Promega Corporation, Southamp-
ton, UK) [24]. The final pellet of DNA was resuspended
in 200 μl molecular-grade water and stored at -80 °C
prior to use. Extraction controls were included within
each group of DNA extractions as described previously
[21]. PCR amplifications, targeting the ITS1 region be-
tween the 18S and 5.8S rRNA genes, were carried out in
duplicate using conditions previously described [25]. In
order to quantify the level of T. gondii DNA present in
the digested chicken tissues (used as the mouse inocula),
any samples positive by ITS1 PCR were also screened
using a quantitative PCR, targeting the 529-bp repeat
element, as previously described [21].
Genetic characterisation of T. gondii
The whole brain from each mouse was homogenised (in
1 ml PBS) by passing tissue through an 18G needle
followed by a 21G needle. DNA was extracted from
400 μl brain homogenate using the method described
above. All 243 samples were initially examined for the
DNA of T. gondii using the nested ITS1 PCR described
above. Samples which were positive were then genotyped
utilising a multiplex nested PCR-RFLP targeting 10
genetic markers, including SAG1, SAG2 (5′-3′ SAG2
and alt.SAG2), SAG3, BTUB, GRA6, c22-8, c29-2, L358,
PK1 and Apico. PCR-RFLP conditions for all markers
were carried out as previously described [21]. Typing
profiles were determined using RFLP banding profiles of
reference strains [26].
In order to compare genotypes of T. gondii isolated
from mouse tissues and chicken tissues, PCR-RFLP was
carried out as described above using DNA extracted
from the digested chicken tissues (mouse inoculum).
Statistical analysis
A two-way ANOVA was used to investigate the effects
of genotype and quantity of T. gondii DNA in the inoc-
ula on the percentage of mouse mortality. A separate
one-way ANOVA with LSD post-hoc tests was used to
further investigate the effect of genotype on the percent-
age of mouse mortality. A P value of < 0.05 was deemed
significant. The statistical software package Minitab 17
was used for all statistical analyses.
Results
Overall, 33 out of 81 (41%) chickens were positive for T.
gondii either by serology (MAT-positive) and/or by ITS1
PCR, whereby T. gondii DNA was detected either in
digested chicken tissues or in the brain tissues of inocu-
lated mice (Table 1). Antibodies to T. gondii were detected
by MAT in 32% (26 of 81) of chickens, with titres of 1:6 in
10, 1:10 in 5, 1:25 in 3, 1:50 in 4, 1:100 in 1, 1:400 in 1,
1:800 in 1, and 1:3200 in 1 chicken (Table 1). Toxoplasma
gondii DNA was detected in the homogenised brain and
heart tissues (used as the mouse inoculum) of 28% (23 of
81) of chickens (Table 1). Of these, 5 had an MAT titre of
1:6, 3 had a titre of 1:10, 2 had a titre of 1:25, 3 had a titre
of 1:50, 1 had a titre of 1:400, 1 had a titre of 1:800, 1 had
a titre of 1:3200, and 7 were seronegative with a titre of
less than or equal to 1:3. Toxoplasma gondii DNA was
detected in mouse brains representing 26% (21 of 81)
chickens, including 4 chickens with an MAT titre of 1:6, 2
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with a titre of 1:10, 2 with a titre of 1:25, 4 with a titre of
1:50, 1 with a titre of 1:400, 1 with a titre of 1:800, 1 with a
titre of 1:3200, and also 6 seronegative chickens with titres
of less than or equal to 1:3.
Thirty out of the 243 mice inoculated [representing 12
out of 81 chickens (15%)] had to be euthanized before
the end of the experiment due to clinical signs of toxo-
plasmosis (Table 2).
Genotyping of 21 isolates from chickens indicated that
14 (67%) were atypical, 6 were ToxoDB genotype #1
(Type II) and one was genotype #2 (Type III) (Table 3 and
Fig. 1). Of the 14 atypical genotypes, 7 were ToxoDB
genotype #141, 3 were genotype #13, 3 were genotype
#265 and 1 was genotype #264. No Type I genotypes
were identified and no mixed infections were found. The
genetic data were based on DNA from one mouse in
each group of 3 mice inoculated with chicken tissues.
For the two chickens which were positive by PCR but
negative in the bioassay, no products could be amplified
at any loci.
Twenty one (21) chickens which tested T. gondii-posi-
tive by ITS1 PCR and also by bioassay (i.e. at least one
out of three mice were positive for T. gondii) had their
tissues tested by qPCR to quantify the amount of T.
gondii DNA present. When comparing the percentage
mortality of mice in the bioassay to the quantity of T.
gondii DNA and the genotype present in the inocula,
there was no significant effect of T. gondii DNA quantity
(F(3,12) = 1.5, P = 0.265) but there was a significant effect
of genotype (F(5,12) = 11.91, P < 0.0001). Post-hoc Fisher
pairwise comparisons revealed that mice inoculated with
genotypes #141 and #13 had significantly higher levels of
mortality (P ≤ 0.05).







MAT and/or PCR POSd
1 St. Georges Basseterre 2/9 2/9 2/9 3/9
2 St. Peters Basseterre 2/9 3/9 2/9 3/9
3 St. Thomas Middle Island 3/9 5/9 5/9 6/9
4 St. Thomas Middle Island 6/9 0/9 1/9 6/9
5 St. Anne Sandy Point 2/9 2/9 2/9 2/9
6 St. Paul Capisterre 4/9 3/9 3/9 4/9
7 St. John Capisterre 1/9 0/9 0/9 1/9
8 Christchurch 2/9 2/9 1/9 2/9
9 St. Mary Cayon 4/9 6/9 5/9 6/9
Total 26/81 (32%) 23/81 (28%) 21/81 (26%) 33/81 (41%)
aNumber of chickens seropositive/number of chickens tested
bNumber of chickens positive for T. gondii DNA (chicken tissues positive by ITS1 PCR)/number of chickens tested
cNumber of chickens positive by bioassay (where brain tissue from at least one mouse out of 3 was positive by ITS1 PCR)/number of chickens tested
dNumber of chickens T. gondii-positive by either serology (MAT) and/or PCR (either chicken tissues or mouse tissues)/Number of chickens tested
Table 2 Burden of Toxoplasma gondii DNA in chicken tissues
(used as mouse inocula)
Chicken IDa qPCR DNA (pg) No. of mice
infected (out of
3 inoculated)
No. of mice euthanized
early due to infection
(% mortality)b
1.6 Pos 0.3 3 0 (0)
1.8 Pos 1.5 3 0 (0)
2.1 Pos 11.1 3 3 (100)
2.3 Pos 1.8 3 3 (100)
2.7 Pos 0.04 0 0 (0)
3.2 Neg 0.0 3 0 (0)
3.4 Pos 0.3 3 0 (0)
3.5 Pos 0.7 3 3 (100)
3.6 Pos 0.1 3 1 (33.3)
3.8 Pos 5.6 3 2 (66.7)
5.1 Pos 6.3 3 3 (100)
5.2 Pos 13.6 3 2 (66.7)
6.1 Pos 21.6 3 3 (100)
6.2 Pos 1.1 3 3 (100)
6.6 Pos 1.9 3 3 (100)
8.1 Neg 0.0 0 0 (0)
8.5 Pos 0.07 3 3 (100)
9.1 Pos 0.2 2 0 (0)
9.2 Pos 2.5 3 0 (0)
9.3 Pos 1.7 3 0 (0)
9.5 Neg 0.0 3 0 (0)
9.8 Pos 0.3 3 0 (0)
9.9 Neg 0.0 0 0 (0)
Abbreviations: Neg, T. gondii qPCR-negative; Pos, T. gondii qPCR-positive
aChickens which were positive by ITS1 PCR
bOne mouse missing from table, it was inoculated with chicken tissues which
were negative by ITS1 PCR and qPCR
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Discussion
The results of this study demonstrate a high prevalence
of T. gondii in free-roaming chickens in St. Kitts and
also reveal a greater genetic diversity of strains circulat-
ing on the island, with potentially different degrees of
virulence to humans. Genotyping of 21 isolates in the
present study revealed a predominance of atypical geno-
types, the majority of which have previously been re-
ported in St. Kitts. Genotypes #264 and #265 were only
very recently isolated from feral dogs in St. Kitts and
were avirulent for mice [22]. Genotypes #141 and #13
were previously isolated from feral cats in St. Kitts
(TgCatStK1 and TgCatStK7, respectively) [18] and,
therefore, further attests to the widespread environmen-
tal contamination with T. gondii oocysts. Genotype #141
has also been isolated from a fox in Pennsylvania, USA,
and, notably, has been demonstrated to be acutely viru-
lent to outbred mice even at low infection levels (10
tachyzoites) [27]. Genotype #13 has previously been
isolated from chickens [16] and a goat [28] in Brazil,
chickens [29] and a dog [30] in Grenada and a howler
monkey in Brazil [31]. While these studies report that
genotype #13 is avirulent for mice, in the present study
8 out of 9 mice inoculated with genotype #13 had to be
euthanized due to clinical signs of toxoplasmosis. This
may have been attributable to the quantity of T. gondii
DNA present in the inocula rather than a reflection of
virulence of the parasite but statistical analyses demon-
strated that quantity of T. gondii DNA in the inocula was
not a significant factor in mortality whereas genotype was,
with significantly more euthanasias being recorded for
mice inoculated with genotypes #13 and #141.
Strains which are virulent for mice are not necessarily
virulent for humans but previous studies have reported
isolating the Caribbean 1 isolate from an AIDS patient
from Martinique where toxoplasmic encephalitis was
recorded at autopsy [32], an AIDS patient from
Guadeloupe who presented with toxoplasmic lymph-
adenopathy and had a previous history of toxoplasmic
encephalitis [32], and a bone marrow transplant patient
from Guadeloupe who died from pulmonary toxoplas-
mosis [32]. The Caribbean 1 isolate has been defined
using microsatellite markers [33, 34] but in the case of
toxoplasmic lymphadenopathy described above, the
isolate has been genotyped using PCR-RFLP and defined
as ToxoDB genotype #13 (Chunlei Su, personal commu-
nication). It is also possible that the other Caribbean 1
isolates (FDF-2007-HEN and CCH-2005-REN) are geno-
type #13 (Daniel Ajzenberg, personal communication).
Further studies are currently underway in our laboratory
to investigate the pathogenicity of the isolates from St.
Kitts; however, the presence of potentially virulent
strains circulating on the island is a public health issue
and officials should take note.
Identifying 7 different genotypes from only 21 isolates
would indicate that the overall genetic diversity of T.
gondii on St. Kitts is relatively high. It appears that the
Caribbean region is more in line with the diversity found
in Central and South America than in North America
and Europe. A recent study looking at geographical
patterns of T. gondii genetic diversity revealed 156 differ-
ent genotypes from 646 South/Central American isolates
(24%) but only 9 genotypes from 64 European isolates
(14%), 10 from 102 Asian isolates (10%), 13 from 141
African isolates (9%) and 40 from 501 North American
isolates (8%) [35].
Worldwide serological prevalence of T. gondii in
chickens varies widely (2–100%) and is dependent on
the method of detection used and the source of chickens
[10]. At present, there is no “gold standard” serological
test for chickens although the MAT is considered the
most specific [36–38]. In the present study, MAT anti-
body titres of ≥ 1:6 were detected in 32% of chickens
tested indicating that these animals have become in-
fected with T. gondii in their environment in St. Kitts.
The seroprevalence rate in St. Kitts is lower than that
reported in the fellow Caribbean island of Grenada
(52%) [12]; however, neither study documented the age
of the animals which could influence results, since older
animals are more likely to be seropositive for T. gondii
[39, 40]. The domestic [17] and feral [18] cat popula-
tions in St. Kitts are known to have high T. gondii sero-
prevalence rates, suggesting that contamination with
oocysts could be widespread on the island. Recent stud-
ies of dogs and livestock in St. Kitts and Nevis reported
seroprevalences of 42% (dogs) [22], 26% (sheep) and 34%
(goats) [21]. Together with the results of the current
study, where chickens were collected from all over the
island, it is evident that there is widespread contamin-
ation with T. gondii oocysts in St. Kitts. This could pose
a potential public health issue given that sporulated,
infective, T. gondii oocysts can survive in the environ-
ment for over a year [41, 42].
The results of the MAT (32% seropositive) were not
too dissimilar to the results of the bioassay (26%
Toxoplasma-positive) and ITS1 PCR on the digested
tissues (28% Toxoplasma-positive) suggesting that the
MAT is a good serological indicator of T. gondii in-
fection. However, of seven chickens which were
deemed seronegative by MAT (titre ≤ 1:3), six were
positive by bioassay (mice were positive by ITS1 PCR
and/or serology) and all seven were ITS1 PCR posi-
tive (DNA extracted from homogenised chicken tis-
sues). Previous reports have demonstrated that T.
gondii could be isolated from defined seronegative
chickens [12, 39] indicating that MAT is perhaps not
as sensitive at detecting early stages of infection when
antibody levels are lower, or it could indicate that the
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chickens were persistently infected and the antibody levels
had declined [43]. A previous study investigating the per-
sistence of T. gondii in tissues of experimentally infected
poultry reported decreasing antibody titres in chickens
four weeks post-infection [43]. This would suggest that
seroprevalence studies may underestimate the true preva-
lence of T. gondii in free-roaming chickens.
It is of note that nine chickens tested positive by MAT
but were negative in the bioassay and ITS1 PCR. This
discrepancy may have been due to the inhomogeneous
distribution of T. gondii tissue cysts in the digested
tissues or because the tissues were no longer harbouring
cysts. Chickens are clinically resistant to T. gondii [10]
and in a recent study of experimentally infected chick-
ens, only 4 out of 192 tested positive by PCR and only
one tissue (heart) was still found to be positive by ten
weeks post-infection [43].
Although we did not test breast muscle or thigh
muscle, it is possible that these tissues may have con-
tained viable T. gondii tissue cysts [10, 44], highlighting
a possible public health risk to the inhabitants of St.
Kitts who handle or consume locally produced chicken
meat [10]. Also, given the evidence for environmental
contamination with oocysts, there is also a potential for
transmission to the population through contaminated
water [45]. Until very recently, there was no data on T.
gondii infection rates in people in St. Kitts. Dubey et al.
[22] conducted a study on pregnant women in the
Caribbean and reported that 8 out of 44 (18%) women
in St. Kitts were seropositive for T. gondii by MAT. This
was comparable to Bermuda (18%) but lower than other
Caribbean islands, including Dominica (59%), St.
Vincent and the Grenadines (54%), St. Lucia (53%),
Grenada (37%), Montserrat (33%), and Antigua and
Barbuda (32%) [22]. Chicken is a popular meat in the
Caribbean and is frequently eaten barbequed which
could pose an infection risk if the meat is infected and
not cooked thoroughly. However, the tendency in this
region is to consume meat (not just chicken) well-done
so the risk of infection is likely to be low, since tissue
cysts are killed at temperatures of over 67 °C for 10 min
[46]. People may be at more risk of infection from a lack
of hand washing after handling raw infected meat, par-
ticularly in the case of backyard farming where chickens
are killed at home and their viscera may be improperly
handled and disposed of [10].
Conclusion
In summary, there is a greater genetic diversity of T.
gondii circulating in the Caribbean region, with po-
tentially different degrees of virulence to humans.
The study also confirms that the environment in St.
Kitts is contaminated with T. gondii oocysts and
highlights chicken meat as a potentially important
source of T. gondii infection if it is handled with poor
hygiene standards or if it is consumed undercooked.
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